|
TMEM5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.375720E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.716800E-03 |
| Normal-vs-Stage2 |
4.189500E-02 |
| Normal-vs-Stage3 |
1.89252999999168E-05 |
| Normal-vs-Stage4 |
8.699600E-03 |
| Stage1-vs-Stage2 |
6.908000E-01 |
| Stage1-vs-Stage3 |
2.612400E-02 |
| Stage1-vs-Stage4 |
4.115000E-01 |
| Stage2-vs-Stage3 |
2.777000E-01 |
| Stage2-vs-Stage4 |
7.637800E-01 |
| Stage3-vs-Stage4 |
4.629400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.413800E-04 |
| Normal-vs-AfricanAmerican |
7.64590000000842E-05 |
| Normal-vs-Asian |
4.075400E-01 |
| Caucasian-vs-AfricanAmerican |
1.228230E-01 |
| Caucasian-vs-Asian |
3.772000E-01 |
| AfricanAmerican-vs-Asian |
2.509600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.322760E-03 |
| Normal-vs-Female |
6.46869999999522E-05 |
| Male-vs-Female |
1.960250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.736400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.830700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.577400E-03 |
| Normal-vs-Age(81-100Yrs) |
9.212700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.418960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.534500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.391200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.750200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.538200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.509620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.775880E-02 |
| Normal-vs-Grade 2 |
3.003400E-03 |
| Normal-vs-Grade 3 |
1.839820E-03 |
| Normal-vs-Grade 4 |
6.41419999999338E-05 |
| Grade 1-vs-Grade 2 |
5.111400E-01 |
| Grade 1-vs-Grade 3 |
4.447000E-01 |
| Grade 1-vs-Grade 4 |
5.485000E-01 |
| Grade 2-vs-Grade 3 |
7.278200E-01 |
| Grade 2-vs-Grade 4 |
2.544400E-02 |
| Grade 3-vs-Grade 4 |
6.500000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.983500E-03 |
| Normal-vs-ccB subtype |
4.620700E-03 |
| ccA subtype-vs-ccB subtype |
9.377800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.780200E-03 |
| Normal-vs-N1 |
2.946200E-01 |
| N0-vs-N1 |
7.824800E-01 |
|
|
